Cristiano Rossitto
Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic
Papers
13
Total Citations
410
H-Index
10
About
Cristiano Rossitto is a pioneering gynecological surgeon whose research has significantly advanced the field of robotic-assisted minimally invasive surgery. Based at a leading Italian center, Rossitto has established himself as one of the foremost clinical investigators of next-generation robotic surgical platforms, with a particular focus on the TELELAP ALF-X and Senhance robotic systems — innovative alternatives to the dominant da Vinci platform. Rossitto's most influential contributions center on demonstrating the feasibility, safety, and clinical outcomes of robotic hysterectomy across diverse patient populations, including challenging cases involving obesity and early-stage endometrial cancer. His 2015 single-center experience with the TELELAP ALF-X garnered 85 citations, establishing foundational evidence for this technology in gynecology. He has also made meaningful contributions to surgical training methodology, examining learning curves for new robotic devices, and to health economics through rigorous cost analyses of robotic operating theater resources. With cumulative citations exceeding 400 across his top works, Rossitto's research spans procedural innovation, comparative surgical outcomes, and urogynecological applications including robotic sacral colpopexy. His body of work has helped shape international adoption of emerging robotic platforms, making him an influential voice in the evolution of minimally invasive gynecological surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 53 mm Senhance robotic hysterectomy: a step towards future perspectives38 citations · 2018
- 6
- 7
- 8
- 9
- 10